Skip to main content
Clinical Trials/JPRN-UMIN000021844
JPRN-UMIN000021844RecruitingPhase 4

Innovative endovascular treatment strategy by angiography, IVUS and pressure gradient guidance in SFA disease with a new nitinol stent system -A prospective multicenter study- - IGNITE study

Japan Endovascular Treatment Conference0 sites300 target enrollmentStarted: April 9, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Acute critical limb ischemia 2) Severe critical limb ischemia (Rutherford category 6) 3) Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel 4) Age < 20 years 5) Life expectancy <2 year due to comorbidity 6) Severe dementia or bedridden case Angiographic criteria 1) Target lesion length > 150 mm by angiographic estimation (TASC II C and D lesion) 2) Previous bypass surgery or stenting of the superficial femoral artery 3) Diseased CFA or distal popliteal artery (P2 or P3 segment) with stenosis more than 50%)

Investigators

Sponsor
Japan Endovascular Treatment Conference

Similar Trials